Yingli Lin

Dr. Yingli Lin

Changhua Christian Hospital, Changhua, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2014 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
ILI-Ching Lin
I-Ching Lin
YYYu-Wen Yang
Yu-Wen Yang
MWMei-Feng Wu
Mei-Feng Wu
YYYi-Hui Yeh
Yi-Hui Yeh
JLJenn-Chang Liou
Jenn-Chang Liou
CCChih-Hsiang Chiang
Chih-Hsiang Chiang
To investigate the association between metabolic syndrome, including its factors, and gallstone disease (GSD) in a Taiwanese population.

1 May 2011 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
YLYingli Lin
Yingli Lin
ILI-Ching Lin
I-Ching Lin
JLJenn-Chang Liou
Jenn-Chang Liou
Patients with end-stage head and neck cancer suffer from many physical and psychological symptoms, however, there have been relatively few studies looking at end-of-life symptoms in the head and neck cancer population. The objective of this study was to describe the symptom patterns of patients with terminal head and neck cancer in the palliative care unit. A retrospective chart review of 94 patients with terminal head and neck cancer admitted to a palliative care unit between May 2006 and December 2008 was performed. Demographic data, performance status, primary tumor site, time from diagnosis to first hospice admission, survival time after admission, medication for pain control, and main symptoms at the time of admission were examined. The mean time from diagnosis to first hospice admission was 33.1 ± 51.6 months. The mean survival time in the hospice was 21.9 ± 18.9 days. In this study, the most common symptom experienced was weight loss, followed by pain, cough, dysphagia, feeding difficulties, and communication difficulties. A statistically significant association of communication difficulties was found with presence or absence of a tracheostomy (p < 0.001). Change of morphine dosage after hospice care is related to the site location of head and neck cancer. Levels of education seem to be related to the increasing use of morphine (p = 0.025). Change of morphine dosage was statistically correlated with survival time after hospice admission (p < 0.001) Numerous symptoms at the end of life highlight the complexity of head and neck cancer patients that may necessitate early hospice referral for symptom control.

16 July 2018 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
KLKun-Hong Li
Kun-Hong Li
YLYen-Tze Liu
Yen-Tze Liu
YYYu-Wen Yang
Yu-Wen Yang
YLYingli Lin
Yingli Lin
MHMin-Ling Hung
Min-Ling Hung
ILI-Ching Lin
I-Ching Lin

1 January 2011 in Internal Medicine
Verified
Journal Article
Open access
PDF file
YLYingli Lin
Yingli Lin
CYChao-Hung Yu
Chao-Hung Yu
Acute myocardial infarction is a life-threatening condition. Coronary dissection after blunt chest trauma is a rare event. Chest pain is a common symptom after chest trauma, which may relate to chest contusion without cardiac injury or myocardial infarction. Differentiation between minor cardiac contusion and significant cardiac injury is difficult and it is a challenge for physicians to diagnose traumatic cardiac injury early. We report a case of a 40-year-old man suffering from coronary artery dissection after a blunt chest trauma and intracranial hemorrhage after percutaneous coronary intervention.

WTWan-Ting Tsai
Wan-Ting Tsai
CCChun-Min Chen
Chun-Min Chen
MCMing-Cheng Chung
Ming-Cheng Chung
PTPei-Yu Tsai
Pei-Yu Tsai
CLClaire Liu
Claire Liu
YLYingli Lin
Yingli Lin
Advance care planning (ACP) and advance directives (ADs) ensure patient autonomy in end-of life care. The number of ADs made and followed in Taiwan is still lacking. This study aimed to determine the factors that influence the willingness to participate in ACP among outpatients in Taiwan. In this study, we conducted a cross-sectional survey based on convenient sampling methods. The questionnaire included questions about participants’ basic sociodemographic information, knowledge of ACP, and awareness of ACP. A total of 198 adults who were outpatients of a family medicine clinic in an affiliated hospital in Taiwan were recruited. The associations between each variable were evaluated using the χ2 test. The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the logistic regression method to examine the influence of each variable on willingness to participate in ACP. Being happy and being a healthcare professional were positively correlated with ACP participation. A lack of ACP knowledge (OR = 0.30 in model A and OR = 0.42 in model C), valuing “Reducing families’ end-of-life decision-making burden” (OR = 2.53 in model B and OR = 2.65 in model C), and a “Belief in a good death” (OR = 4.02 in model B and OR = 4.10 in Model C) were the main factors affecting subjects’ willingness to participate in ACP. Knowing which factors influence willingness to participate in ACP helps in the promotion of ACP. Continuously educating both the general public and healthcare professionals strengthens knowledge about the right to autonomy, about its associated laws, and about the ACP process, and thus, programs should be created to provide this education. Additionally, taking into account the differences between cultures can be helpful.

25 June 2025 in eClinicalMedicine
Verified
Journal Article
Open access
YLYingli Lin
Yingli Lin
SWShiow-Ing Wang
Shiow-Ing Wang
CHENGCHUNG WEICHENGCHUNG WEI
CHENGCHUNG WEI
Patients with rheumatoid arthritis (RA) are at increased risk of developing herpes zoster (HZ). This study aimed to assess the effectiveness of recombinant zoster vaccine (RZV) in reducing both the incidence of HZ and all-cause mortality among individuals with RA. We conducted a retrospective cohort study using data from the TriNetX U.S. Collaborative Network between October 1, 2017 and March 31, 2024. The study population consisted of patients with RA who received RZV (RA-RZV cohort) and those who did not (RA control cohort). Propensity score matching (PSM) was employed to balance baseline characteristics between the groups, accounting for demographics, social economic status, lifestyles, medical utilization, comorbidities, and medications. The primary outcomes were the risk of HZ and all-cause mortality. PSM-adjusted hazard ratios (HRs) were calculated using Cox proportional hazards regression models. Kaplan–Meier curves and Log-Rank tests were used to evaluate survival differences. After PSM, each cohort included 21,046 individuals. The RA-RZV group demonstrated significantly lower risks of HZ (HR: 0.836, 95% CI: 0.738–0.947) and all-cause mortality (HR: 0.606, 95% CI: 0.561–0.654). The HZ risk reduction was more pronounced in patients aged 50–64 years (HR: 0.731, 95% CI: 0.610–0.876), females (HR: 0.791, 95% CI: 0.684–0.915), White (HR: 0.808, 95% CI: 0.696–0.937), and Black/African American participants (HR: 0.685; 95% CI: 0.481–0.976). RZV vaccination is associated with a reduced risk of HZ among patients with RA aged 50 years and older. While we observed a reduction in all-cause mortality among RZV recipients, this finding should be interpreted with caution, as the effect size may not be entirely attributable to HZ prevention alone. Given the established efficacy of RZV in preventing HZ and its potential to reduce mortality, vaccination should be prioritized among eligible patients with RA. There is no funding.